Trial Profile
A pharmacokinetic study of mycophenolate mofetil in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 26 Nov 2015
Price :
$35
*
At a glance
- Drugs Mycophenolate mofetil (Primary)
- Indications Anti-neutrophil cytoplasmic antibody-associated vasculitis
- Focus Pharmacokinetics
- 26 Nov 2015 New trial record